Tumors need higher-than-normal amounts of energy and the molecular building blocks needed to build new cellular components to fuel phases of fast and aggressive growth. Cancer cells therefore consume a lot of sugar (glucose A number of tumors are also able to catabolize the amino acid glutamine, an important building block of proteins). A key enzyme in amino acid decomposition is isocitrate dehydrogenase (IDH). Several years ago, scientists discovered mutations in the gene coding for IDH in numerous types of brain cancer. Very malignant brain tumors called primary glioblastomas carry an intact IDH gene, whereas those that grow more slowly usually have a defective form. "The study of the IDH gene currently is one of the most important diagnostic criteria for differentiating glioblastomas from other brain cancers that grow more slowly," says Dr. Bernhard Radlwimmer from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). "We wanted to find out what spurs the aggressive growth of glioblastomas." In collaboration with scientists from other institutes including Heidelberg University Hospital, Dr. Martje Tönjes and Dr. Sebastian Barbus from Radlwimmer's team compared gene activity profiles from several hundred brain tumors. They aimed to find out whether either altered or intact IDH show further, specific genetic characteristics that might help explain the aggressiveness of the disease. The researchers found a significant difference between the two groups in the highly increased activity of the gene for the BCAT1 enzyme, which in normal brain tissue is responsible for breaking down so-called branched-chain amino acids. However, Radlwimmer's team discovered, only those tumor cells whose IDH gene is not mutated produce BCAT1. "This is not surprising, because as IDH breaks down amino acids, it produces ketoglutarate - a molecule which BCAT1 needs. This explains why BCAT1 is produced only in tumor cells carrying intact IDH. The two enzymes seem to form a kind of functional unit in amino acid catabolism," says Bernhard Radlwimmer. Glioblastomas are particularly dreaded because they aggressively invade the healthy brain tissue that surrounds them. When the researchers used a pharmacological substance to block BCAT1's effects, the tumor cells lost their invasive capacity. In addition, the cells released less of the glutamate neurotransmitter. High glutamate release is responsible for severe neurological symptoms such as epileptic seizures, which are frequently associated with the disease. When transferred to mice, glioblastoma cells in which the BCAT1 gene had been blocked no longer grew into tumors. "Altogether, we can see that overexpression of BCAT1 contributes to the aggressiveness of glioblastoma cells," Radlwimmer says. The study suggests that the two enzymes, BCAT1 and IDH, cooperate in the decomposition of branched-chain amino acids. These protein building blocks appear to act as a "food source" that increases the cancer cells' aggressiveness. Branched-chain amino acids also play a significant role in metabolic diseases such as diabetes. This is the first time that scientists have been able to show the role of these amino acids in the growth of malignant tumors. "The good news," sums up Radlwimmer, "is that we have found another target for therapies in BCAT1. In collaboration with Bayer Healthcare, we have already started searching for agents that might be specifically directed against this enzyme." The researchers also plan to investigate whether BCAT1 expression may serve as an additional marker to diagnose the malignancy of brain cancer. Source: Eurekalert << Starting on 3 Drugs at Time of Diagnosis Benefits Type 2 Di... New Light on Sickle Cell Crisis Shed By Computer Models >> Recommended Reading Biomarker That Safely Monitors Tumor Response to New Brain Cancer Treatment Identified Scientists have identified an effective tool in the form of a biomarker in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme READ MORE Research Reveals Mechanism of Mutant Histone Protein in Childhood Brain Cancer Most of the cancer treatments are blunt. Oncologists often turn to radiation or chemotherapy, in an attempt to eradicate tumors which can damage healthy tissue along with the cancerous growths. READ MORE Ataxia Ataxia affects coordination. Gait becomes unstable and the patient loses balance. The cerebellum or its inputs and/or outputs are affected. READ MORE Brain Tumor Up to date information about brain tumor, the most common solid tumor in children and the third leading cause of death in young adults. It impairs an individuals physical and cognitive abilities. READ MORE Hungry? - But you Just Ate! Most of us are tempted by good food, mealtime or not. Once in a way is fine but it is dangerous to give into food cravings all the time. READ MORE Parkinsons Disease Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent. READ MORE Spirulina Spirulina is a blue-green algae that is grown globally as a health supplement. Of late there is an effort to promote spirulina as the “food of the future”. READ MORE Tumor Markers For Cancer Diagnosis and Prognosis An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results. READ MORE Most Popular on Medindia Loram (2 mg) (Lorazepam) Blood Pressure Calculator Find a Hospital More News on: Parkinsons DiseaseParkinsons Disease Surgical TreatmentBrain TumorBrain TumorsBrainTumor Markers For Cancer Diagnosis and PrognosisBrain FactsAtaxiaSpirulinaHungry? - But you Just Ate!